We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AVNT's Growth Catalysts: Defense Capacity and Chip Packaging Tailwinds
Read MoreHide Full Article
Key Takeaways
Avient leans on defense, healthcare and chip packaging to drive steadier margins into 2026.
AVNT boosts Dyneema capacity via process innovation, with added output now and expansion by 2028.
Avient sees double-digit chip packaging growth and plans higher capex to meet demand.
Avient Corporation (AVNT - Free Report) is leaning into end markets that can support steadier margins even when broader volumes are uneven. The mix is shifting toward defense, healthcare, telecommunications and chip packaging, supported by a disciplined productivity engine. That combination is a key reason the company expects additional margin expansion in 2026.
The next phase of the story is less about a fast-cycle rebound and more about capacity, execution, and where management is placing incremental investment.
Dyneema and Defense as a Multi-Year Driver for AVNT
Defense-related demand and Dyneema capacity investments are positioned as a multi-year growth driver for Avient’s Specialty Engineered Materials segment. Management has pointed to sustained defense strength, following an 8% growth in defense in 2025.
Dyneema, acquired as part of DSM’s protective materials business in 2022, broadened Avient’s footprint in advanced composites and engineered fiber materials. That portfolio expansion increases exposure to higher-performance applications, where engineered materials can carry more durable pricing and margin profiles.
One of the most visible operational catalysts is a proprietary process innovation designed to debottleneck existing Dyneema lines. The practical takeaway is that Avient expects to lift near-term output without major slowdowns, which creates a measurable milestone investors can track across 2026.
Additional capacity tied to the current investment is expected to come online in 2028. Together, the near-term debottlenecking and the later step-up create a clearer runway for volume conversion and mix-led margin support beyond the next few quarters.
Capex Shift Signals Where Avient Sees Demand
Capital spending plans reinforce where management sees the best demand visibility. For 2026, capital expenditure is planned at roughly $140 million, about $33 million higher than 2025, and is concentrated on defense and Dyneema.
Importantly, management has characterized the limiting factor as capacity and execution rather than end-market appetite. In that context, the increase in capital spending reads as a deliberate effort to remove bottlenecks and capture demand that is already present.
Chip and Wafer Packaging Momentum in Asia
Chip and wafer packaging materials are cited as a double-digit growth area, particularly in Asia. That demand trend reinforces Specialty Engineered Materials' strength and supports the broader narrative of mix shifting toward structurally stronger end markets.
This fits the broader theme of mix shifting toward markets with steadier end-demand drivers, which can help sustain profitability even when consumer, industrial or construction trends are choppy.
CAI Recovery Setup Through Packaging Improvement
The Color, Additives and Inks (CAI) segment posted a 2% organic decline in 2025, yet still improved margin by 50 basis points on mix and productivity. That combination suggests the segment can protect profitability even when volumes are not fully supportive.
The 2026 setup is geared toward packaging improvement. In the United States, packaging is expected to turn positive in the first quarter. Asia is positioned to benefit from packaging share gains, alongside ongoing demand tied to chip and wafer packaging materials. These drivers are central to the company’s expectation for CAI improvement during 2026.
What to Watch Through 2026
A practical checklist through 2026 starts with evidence that defense strength is sustained and that Dyneema throughput improvements are showing up in output. Investors will also want to see packaging improvement flow through CAI as expected, particularly in the United States starting in the first quarter, alongside continued share and demand benefits in Asia.
Execution on productivity remains central, especially with a baseline net inflation headwind of roughly $30 million in 2026. Finally, progress on deleveraging should remain visible while the company funds higher capital spending, with management expecting to exit 2026 below 2.5x net leverage.
Peers in the Zacks Chemical - Diversified industry include Cabot Corporation (CBT - Free Report) and Methanex Corporation (MEOH - Free Report) , carrying a Zacks Rank #4 (Sell) and Zacks Rank #3, respectively.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
AVNT's Growth Catalysts: Defense Capacity and Chip Packaging Tailwinds
Key Takeaways
Avient Corporation (AVNT - Free Report) is leaning into end markets that can support steadier margins even when broader volumes are uneven. The mix is shifting toward defense, healthcare, telecommunications and chip packaging, supported by a disciplined productivity engine. That combination is a key reason the company expects additional margin expansion in 2026.
The next phase of the story is less about a fast-cycle rebound and more about capacity, execution, and where management is placing incremental investment.
Dyneema and Defense as a Multi-Year Driver for AVNT
Defense-related demand and Dyneema capacity investments are positioned as a multi-year growth driver for Avient’s Specialty Engineered Materials segment. Management has pointed to sustained defense strength, following an 8% growth in defense in 2025.
Dyneema, acquired as part of DSM’s protective materials business in 2022, broadened Avient’s footprint in advanced composites and engineered fiber materials. That portfolio expansion increases exposure to higher-performance applications, where engineered materials can carry more durable pricing and margin profiles.
Avient Corporation Price and Consensus
Avient Corporation price-consensus-chart | Avient Corporation Quote
Process Innovation and the 2028 Capacity Step-Up
One of the most visible operational catalysts is a proprietary process innovation designed to debottleneck existing Dyneema lines. The practical takeaway is that Avient expects to lift near-term output without major slowdowns, which creates a measurable milestone investors can track across 2026.
Additional capacity tied to the current investment is expected to come online in 2028. Together, the near-term debottlenecking and the later step-up create a clearer runway for volume conversion and mix-led margin support beyond the next few quarters.
Capex Shift Signals Where Avient Sees Demand
Capital spending plans reinforce where management sees the best demand visibility. For 2026, capital expenditure is planned at roughly $140 million, about $33 million higher than 2025, and is concentrated on defense and Dyneema.
Importantly, management has characterized the limiting factor as capacity and execution rather than end-market appetite. In that context, the increase in capital spending reads as a deliberate effort to remove bottlenecks and capture demand that is already present.
Chip and Wafer Packaging Momentum in Asia
Chip and wafer packaging materials are cited as a double-digit growth area, particularly in Asia. That demand trend reinforces Specialty Engineered Materials' strength and supports the broader narrative of mix shifting toward structurally stronger end markets.
This fits the broader theme of mix shifting toward markets with steadier end-demand drivers, which can help sustain profitability even when consumer, industrial or construction trends are choppy.
CAI Recovery Setup Through Packaging Improvement
The Color, Additives and Inks (CAI) segment posted a 2% organic decline in 2025, yet still improved margin by 50 basis points on mix and productivity. That combination suggests the segment can protect profitability even when volumes are not fully supportive.
The 2026 setup is geared toward packaging improvement. In the United States, packaging is expected to turn positive in the first quarter. Asia is positioned to benefit from packaging share gains, alongside ongoing demand tied to chip and wafer packaging materials. These drivers are central to the company’s expectation for CAI improvement during 2026.
What to Watch Through 2026
A practical checklist through 2026 starts with evidence that defense strength is sustained and that Dyneema throughput improvements are showing up in output. Investors will also want to see packaging improvement flow through CAI as expected, particularly in the United States starting in the first quarter, alongside continued share and demand benefits in Asia.
Execution on productivity remains central, especially with a baseline net inflation headwind of roughly $30 million in 2026. Finally, progress on deleveraging should remain visible while the company funds higher capital spending, with management expecting to exit 2026 below 2.5x net leverage.
AVNT currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Peers in the Zacks Chemical - Diversified industry include Cabot Corporation (CBT - Free Report) and Methanex Corporation (MEOH - Free Report) , carrying a Zacks Rank #4 (Sell) and Zacks Rank #3, respectively.